Drugs / ORAL7®
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07627945 | Oct 2025 → Jun 2026 | impacted teeth, multiple | MBD MARKETING SDN. BHD. | Completed | No outcome recorded |
| — | NCT06984848 | Sep 2025 → Dec 2026 expected | — | ZAINAB MAT YUDIN | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oral7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06984848 ↗ |
| Modality | Protein / enzyme biologic | “ORAL7® is an enzyme-based oral rinse formulated to mimic components of the innate salivary defense system.” NCT07627945 ↗ |
| Route | Oral | “Participants will be instructed to rinse with approximately 10 mL of the mouthwash for 30 seconds, three times daily for 7 days starting on the first postoperative day.” NCT07627945 ↗ |